cetuximab

(redirected from Erbitux)
Also found in: Medical.

cetuximab

(sɪˈtʌksɪˌmæb)
n
a monoclonal antibody used to treat cancer
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014
References in periodicals archive ?
M2 EQUITYBITES-July 8, 2019-Array BioPharma Inc updates results of Phase 3 BEACON CRC trial of BRAFTOVI MEKTOVI and ERBITUX in patients with advanced colorectal cancer
Global Banking News-July 8, 2019-Array BioPharma Inc updates results of Phase 3 BEACON CRC trial of BRAFTOVI MEKTOVI and ERBITUX in patients with advanced colorectal cancer
M2 PHARMA-July 8, 2019-Array BioPharma Inc updates results of Phase 3 BEACON CRC trial of BRAFTOVI MEKTOVI and ERBITUX in patients with advanced colorectal cancer
Pfizer executives said the company began actively pursuing Array last month after it released positive clinical data showing that Braftovi and Mektovi, in combination with Eli Lilly's Erbitux, helped reduce the risk of death from colorectal cancer by 48 per cent.
Array BioPharma announced positive results from the interim analysis of the Phase 3 BEACON CRC trial evaluating the combination of BRAFTOVI, MEKTOVI, and ERBITUX in patients with BRAFV600E-mutant metastatic colorectal cancer, following one or two prior lines of therapy.
* Erbitux (cetuximab; Eli Lilly/Merck): What limits the use of Erbitux in first-line HNSCC treatment?
In terms of targeted treatments, the metastatic CRC treatment landscape is mature, including the branded treatments Avastin (bevacizumab), Erbitux (cetuximab), and Vectibix (panitumumab), treatments that have extended the survival of metastatic patients compared to chemotherapy-only regimens.
Increases largely came from the General Medicine franchise (including cardiometabolic care) and oncology drug Erbitux. In geographic terms, Emerging Markets and Japan fueled this growth, posting increases of 12% and 17%, respectively.
Curcumin exhibits activities similar to recently discovered tumor necrosis factor blockers (e.g, HUMIRA, REMICADE, and ENBREL), a vascular endothelial cell growth factor blocker (e.g., AVASTIN), human epidermal growth factor receptor blockers (e.g., ERBITUX, ERLOTINIB, and GEFTINIB), and a HER2 blocker (e.g., HERCEPTIN).
regulators delayed a review of the cladribine multiple sclerosis pill, the drug failed to win European approval and cancer therapy Erbitux was rejected for use against lung cancer in Europe.
In this study, Ulrich Gatzemeier from Hospital Grosshansdorf in Germany and colleagues did a subgroup analysis of patients from the First-Line Erbitux in Lung Cancer (FLEX) study to assess whether the development of an acne-like rash in the first 3 weeks of treatment (first-cycle rash) correlated with clinical outcome.
Summary: EoACAo Erbitux plus chemotherapy produces positive results in the difficult to treat triple-negative breast cancer despite not meeting primary endpoint of response rate